Bank of America raised its price objective and issued a buy rating on Eli Lilly and Company stock on July 25, 2026.
4 reports, 1 independent
Updated Jul 26
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 4
- Developments
- 1
- Repetition
- 75%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Bank of America raised its price objective and issued a buy rating on Eli Lilly and Company stock on July 25, 2026.
Who's involved
What this event is mainly aboutKeep exploring
Part of
Analyst coverage is influencing stock price targets for companies including Bank of America, Eli Lilly and Company, Leerink partners, and Cantor Fitzgerald.Also in this story
- Bank of America and Citigroup issued buy ratings and raised price targets on July 18, 2026.
- Copeland Capital Management reduced its stake in Eli Lilly and Company shares.
- Berenberg Bank and Leerink Partners raised price targets for Eli Lilly and Company on July 8, 2026.
The entities involved
-
Bank of America
American multinational banking and financial services corporation
-
Eli Lilly and Company
American pharmaceutical company
Related events
- Berenberg Bank raised a price target and gave a 'hold' rating on Eli Lilly and Company, alongside filing required reports with the SEC.
- Truist Financial and Leerink Partners raised price objectives for Eli Lilly and Company stock.
- Bank of America restated a buy rating on an unnamed company on August 17, 2026.
- BlackRock raised its target price and gave a buy rating for Bank of America.
- Bank of America and Raymond James Financial raised their ratings and increased price targets for Okta.
Coverage
Newest first; wire copies grouped- tickerreport.comVan Diest Capital LLC Acquires 495 Shares of Eli Lilly and Company $LLY
- tickerreport.comSt. Louis Trust Co Has $1.57 Million Stock Holdings in Eli Lilly and Company $LLY